Affinity Asset Advisors’s Amgen AMGN Stock Holding History

Affinity Asset Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,000	Closed	-$5.25M	–	75
2022 Q4	$5.25M	Buy	+20,000	New	+$5.36M	2.06%	17

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Affinity Asset Advisors's AMGN Position: Q1 2026 in Review

Affinity Asset Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 10,000 shares — an estimated $3.27M sold.

Affinity Asset Advisors first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $3.27M in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Affinity Asset Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Affinity Asset Advisors sold 10,000 Amgen shares in Q1 2026, an estimated $3.27M.
Affinity Asset Advisors first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
Affinity Asset Advisors's Amgen position peaked at $3.27M in Q4 2025.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.